According to Hester Biosciences 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.88656. At the end of 2023 the company had a P/S ratio of 4.21.
Year | P/S ratio | Change |
---|---|---|
2023 | 4.21 | -27.09% |
2022 | 5.78 | -34.67% |
2021 | 8.85 | 16.01% |
2020 | 7.62 | 19.89% |
2019 | 6.36 | -0.87% |
2018 | 6.42 |